FunPep News

FunPep: Notice Concerning Mass Exercise of the 11th Stock Acquisition Rights (with Exercise Price Amendment Clauses)

Sep 18 16:00

FunPep: Notice regarding the recording of non-operating income (subsidy income)

Sep 13 14:00

FunPep: Notice Concerning Mass Exercise of the 11th Stock Acquisition Rights (with Exercise Price Amendment Clauses)

Sep 11 15:20

FunPep: Notice Concerning Mass Exercise of the 11th Stock Acquisition Rights (with Exercise Price Amendment Clauses)

Sep 5 15:30

FunPep: Notice regarding the monthly exercise status of the 11th Stock Acquisition Rights (with exercise price amendment clause)

Sep 2 14:00

FunPep: Notice of patent establishment (US) relating to anti-IgE antibody-inducing peptides

Aug 30 14:00

FunPep: Announcement regarding the progress of research on next-generation formulation technology for antibody-inducing peptides.

Aug 21 14:00

FunPep: Announcements of individual stocks regarding the mass exercise of the 11th subscription rights (with a modification clause for exercise price).

Aug 19 14:45

FunPep: Announcements of individual stocks regarding the mass exercise of the 11th subscription rights (with a modification clause for exercise price).

Aug 16 15:45

FunPep: Announcements of individual stocks regarding the release of cosmetic products containing our subsidiary's beauty ingredient, OSK9.

Aug 16 14:00

FunPep: Announcements of individual stocks regarding the mass exercise of the 11th subscription rights (with a modification clause for exercise price).

Aug 8 16:00

FunPep: Announcements of individual stock: Notice of changes in major shareholders

Aug 7 16:00

FunPep: Announcements of individual stocks: Commencement of AI drug discovery research for antibody-inducing peptides.

Aug 7 14:00

FunPep: Announcements of individual stocks regarding the monthly exercise status of the 11th subscription rights (with exercise price adjustment clause).

Aug 1 14:30

FunPep: Matters related to business plans and growth potential.

Jul 5 14:30

FunPep: Announcements of individual stocks: Addition of phase 3 clinical trial for functional peptide 'SR-0379' - Implementation notice.

Jul 5 14:00

FunPep: Announcements of the latest development status of allergy vaccines

Jun 7 14:00

FunPep: Announcements of individual stocks: Exclusive license agreement signed for antibody-inducing peptide "FPP004X".

Jun 5 14:00

FunPep: Articles of Incorporation 2024/03/27

Apr 16 13:29

FunPep: Stock Transfer Report Affirmations Related to Third-Party Allocation (New Shares)

Mar 25 09:00